Five Successful Publication Years

This issue of Homeopathy marks a full five publication years with Georg Thieme Verlag KG. The transfer of the journal's production from Elsevier in December 2017 was the start of what has been a highly successful period of collaboration between the Faculty of Homeopathy (the journal's owners) and Thieme Publishers. Initially as Senior Deputy Editor, and now as Editor, I personally have enjoyed a greatly rewarding and happy working relationship with exceptional and dedicated colleagues at Thieme: Graham Brumfield, Senior Executive Editor; Jessica Bogensberger, Executive Editor; Aakanksha Bhatnagar, Associate Editor; and, in Production over the years, Project Managers Manpreet Kaur, Ananya Das and Swaraj Boruah. Our fifth year with Thieme sees the journal's Impact Factor attain its highest-ever value (1.818), a tribute to the high quality of our authors' original work, our rigorous peer-review process, and the professional presentation of the journal online and in print.

This issue's variety of articles includes reports at the levels of a national health service, multi- or single-centered clinical trial, in vitro laboratory investigation, and individual clinical case – every one of them from either Brazil or India. The impact of national strategic guidelines on developing public homeopathy services in Brazil is the subject of work reported from São Paulo.[1] Randomized trials from Kolkata[2] and Bhopal,[3] on acne and COVID-19 respectively, and a parallel cluster cohort study from COVID-19 containment areas of Delhi,[4] feature as our clinical research in this issue. The findings from three in vitro studies are intriguing, for each of them indicates a homeopathic medicine's potential benefits that ensued from the inhibition of a harmful underlying biological process: limiting the development of blow-fly larvae that causes myiasis in sheep;[5] retarding the growth or migration of breast cancer cells.[6] [7] The clinical report published in this issue is a rare presentation of male infertility, managed effectively with individualized homeopathy.[8]

Publication History

Article published online:
15 November 2022

• References

• 1 Lemonica R, Patricio KP. Impact of the national policy on integrative and complementary practices on Brazilian public homeopathy services. Homeopathy 2022; 111: 235-239
• 2 Rai S, Gupta GN, Singh S. et al. Efficacy of individualized homeopathic medicines in treatment of acne vulgaris: a double-blind, randomized, placebo-controlled trial. Homeopathy 2022; 111: 240-251
• 3 Varanasi R, Tomar S, Gupta S. et al. Comparative effectiveness of pre-identified homeopathic medicines in asymptomatic COVID-19 individuals receiving standard care–An open-label, randomized, controlled exploratory trial. Homeopathy 2022; 111: 252-260
• 4 Nayak D, Nahar K, Bhalerao R. et al. Effectiveness of Arsenicum album 30C in prevention of COVID-19 in individuals residing in containment zones of Delhi–A prospective, community-based, parallel cohort study. Homeopathy 2022; 111: 261-270
• 5 Barros GP, Avilés LLA, Hillmann MCH, Bricarello PA. Effect of ointments of Sulphur or Pyrogenium on larvae of Cochliomyia hominivorax (Diptera: Calliphoridae). Homeopathy 2022; 111: 271-277
• 6 Silva TC, Santos WA, Pinto SAG, Rocha PRD, Hurtado ECP, Bonamin LV. Phenotypic changes on mammary adenocarcinoma (4T1) cells in vitro after treatment with Carcinosinum . Homeopathy 2022; 111: 278-287
• 7 Basu N, Narad P, Guptasarma ML, Tandon C, Das BC, Tandon S. Computational and in vitro approaches to elucidate the anti-cancer effects of Arnica montana in hormone-dependent breast cancer. Homeopathy 2022; 111: 288-300
• 8 Ramanan VE, Sathyanandhan S. A case report of idiopathic OAT syndrome, associated with necrospermia and hypospermia, reversed with individualized homeopathy. Homeopathy 2022; 111: 301-306